1. Home
  2. TMUS vs ABT Comparison

TMUS vs ABT Comparison

Compare TMUS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo T-Mobile US Inc.

TMUS

T-Mobile US Inc.

N/A

Current Price

$216.79

Market Cap

224.7B

ML Signal

N/A

ABT

Abbott Laboratories

N/A

Current Price

$115.37

Market Cap

189.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TMUS
ABT
Founded
1994
1888
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.7B
189.6B
IPO Year
2004
2006

Fundamental Metrics

Financial Performance
Metric
TMUS
ABT
Price
$216.79
$115.37
Analyst Decision
Buy
Strong Buy
Analyst Count
18
18
Target Price
$258.00
$141.00
AVG Volume (30 Days)
6.5M
9.4M
Earning Date
05-13-2026
04-23-2026
Dividend Yield
1.87%
2.20%
EPS Growth
0.62
N/A
EPS
9.72
3.72
Revenue
$40,604,000,000.00
$44,328,000,000.00
Revenue This Year
$9.30
$8.92
Revenue Next Year
$4.52
$7.39
P/E Ratio
$22.50
$30.85
Revenue Growth
9.03
5.67
52 Week Low
$181.36
$105.27
52 Week High
$276.49
$141.23

Technical Indicators

Market Signals
Indicator
TMUS
ABT
Relative Strength Index (RSI) 62.89 55.40
Support Level $202.37 $105.27
Resistance Level $244.81 $129.65
Average True Range (ATR) 6.06 1.86
MACD 1.04 0.98
Stochastic Oscillator 79.49 96.94

Price Performance

Historical Comparison
TMUS
ABT

About TMUS T-Mobile US Inc.

Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 85 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers with its wireless network. It also serves nearly 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Share on Social Networks: